ViiV expands licensing deal for its HIV drug in low-income countries
Once again, ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, reflecting ongoing pressure to respond to criticism. Under the latest arrangement, the company is expanding a licensing agreement reached three years ago with the Medicines Patent Pool, which is backed by the United Nations and […]